These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36712458)

  • 1. A case report: New-onset refractory status epilepticus in a patient with
    Astner-Rohracher A; Mauritz M; Leitinger M; Rossini F; Kalss G; Neuray C; Retter E; Wortmann SB; Achleitner MT; Mayr JA; Trinka E
    Front Neurol; 2022; 13():1063733. PubMed ID: 36712458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to FIRE NORSE: A single acronym for a heterogeneous presentation. Further information from a case series and discussion of the literature.
    Alaskar AM; Aljohani MA; Dionisio S; Asiry MA; Alqadi K
    J Neuroimmunol; 2024 Mar; 388():578298. PubMed ID: 38330780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of etiologies according to baseline clinical features of pediatric new-onset refractory status epilepticus in single center retrospective study.
    Lee S; Kim SH; Kim HD; Lee JS; Ko A; Kang HC
    Seizure; 2024 Jun; 120():49-55. PubMed ID: 38908141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
    Sheikh Z; Hirsch LJ
    Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathology of New-Onset Refractory Status Epilepticus (NORSE).
    Hanin A; Cespedes J; Huttner A; Strelnikov D; Gopaul M; DiStasio M; Vezzani A; Hirsch LJ; Aronica E
    J Neurol; 2023 Aug; 270(8):3688-3702. PubMed ID: 37079033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE).
    Costello DJ; Matthews E; Aurangzeb S; Doran E; Stack J; Wesselingh R; Dugan P; Choi H; Depondt C; Devinsky O; Doherty C; Kwan P; Monif M; O'Brien TJ; Sen A; Gaspard N
    Epilepsia; 2024 Jun; 65(6):1581-1588. PubMed ID: 38498313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cryptogenic new-onset refractory status epilepticus (C-NORSE) with tocilizumab: A case report.
    Nakamura Y; Ueda M; Kodama S; Kimura T; Shirota Y; Hamada M; Ishiura H; Iizuka T; Toda T
    Intern Med; 2024 Apr; ():. PubMed ID: 38658340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizure burden and neuropsychological outcomes of new-onset refractory status epilepticus: Systematic review.
    Taraschenko O; Pavuluri S; Schmidt CM; Pulluru YR; Gupta N
    Front Neurol; 2023; 14():1095061. PubMed ID: 36761344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine as a potential therapeutic option for super-refractory status epilepticus: A case report.
    Sugata M; Kataoka H; Uchihara Y; Shimada D; Atagi K; Nakamura M; Hara M; Kawahara M; Sugie K
    J Cent Nerv Syst Dis; 2023; 15():11795735231200740. PubMed ID: 37692459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review and standard operating procedures for collection of biospecimens and analysis of biomarkers in new onset refractory status epilepticus.
    Hanin A; Cespedes J; Pulluru Y; Gopaul M; Aronica E; Decampo D; Helbig I; Howe CL; Huttner A; Koh S; Navarro V; Taraschenko O; Vezzani A; Wilson MR; Xian J; Gaspard N; Hirsch LJ
    Epilepsia; 2023 Jun; 64(6):1444-1457. PubMed ID: 37039049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe and effective implantation and use of vagal nerve stimulation in new-onset refractory status epilepticus in early pregnancy: a case report.
    Jindal M; Delaj L; Winston J; Goel R; Bhatti S; Angelova-Chee M; Selway R; Mantoan Ritter L
    Front Neurol; 2023; 14():1183080. PubMed ID: 37255724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seasonality of new-onset refractory status epilepticus (NORSE).
    Gopaul MT; Hanin A; Cespedes J; Pulluru Y; Kazazian K; van Baalen A; Gofton TE; Gaspard N; Hirsch LJ
    Epilepsia; 2023 Jun; 64(6):e112-e117. PubMed ID: 37013696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease: a case report].
    Nakada R; Terasawa Y; Sato T; Takatsu H; Kaito N; Iguchi Y
    Rinsho Shinkeigaku; 2023 Dec; 63(12):843-846. PubMed ID: 37989289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-Onset Refractory Status Epilepticus Due to a Novel MT-TF Variant: Time for Acute Genetic Testing Before Treatment?
    Indelicato E; Pfeilstetter J; Zech M; Unterberger I; Wanschitz J; Berweck S; Boesch S
    Neurol Genet; 2023 Apr; 9(2):e200063. PubMed ID: 37090940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell Transcriptomic Analyses of Brain Parenchyma in Patients With New-Onset Refractory Status Epilepticus (NORSE).
    Hanin A; Zhang L; Huttner AJ; Plu I; Mathon B; Bielle F; Navarro V; Hirsch LJ; Hafler DA
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200259. PubMed ID: 38810181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5-year-old boy with super-refractory status epilepticus and RANBP2 variant warranting life-saving hemispherotomy.
    Straka B; Koblížek M; Splítková B; Valkovičová R; Krsková L; Kalinová M; Vlčková M; Zámečník J; Laššuthová P; Sedláčková L; Staněk D; Maulisová A; Tichý M; Kynčl M; Kršek P
    Epilepsia Open; 2024 Feb; 9(1):424-431. PubMed ID: 37943122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The etiology and mortality of new-onset refractory status epilepticus (NORSE) in adults: A systematic review and meta-analysis.
    Tharmaraja T; Ho JSY; Neligan A; Rajakulendran S
    Epilepsia; 2023 May; 64(5):1113-1124. PubMed ID: 36727541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier damage and new onset refractory status epilepticus: An exploratory study using dynamic contrast-enhanced magnetic resonance imaging.
    Li H; Liu X; Wang R; Lu A; Ma Z; Wu S; Lu H; Du Y; Deng K; Wang L; Yuan F
    Epilepsia; 2023 Jun; 64(6):1594-1604. PubMed ID: 36892496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspective: Vagal nerve stimulation in the treatment of new-onset refractory status epilepticus.
    Mantoan Ritter L; Selway R
    Front Neurol; 2023; 14():1172898. PubMed ID: 37153661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Increased Interleukin-6 Levels Can Be an Early Diagnostic Marker for New-Onset Refractory Status Epilepticus.
    Kwack DW; Kim DW
    J Epilepsy Res; 2022 Dec; 12(2):78-81. PubMed ID: 36685741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.